caafimaadka

Ku dhawaaqida soo bandhigida neerfaha cusub ee tallaalka Corona

Ku dhawaaqida soo bandhigida neerfaha cusub ee tallaalka Corona

Ku dhawaaqida soo bandhigida neerfaha cusub ee tallaalka Corona

Hay'adda dawooyinka Yurub ayaa Arbacadii ku dhawaaqday, inay liiska Guillain-Barré syndrome, cillad neerfayaasha naadir ah, ku sheegtay saameyn "aad u naadir ah" oo uu leeyahay tallaalka AstraZeneca ee ka dhanka ah Covid-19.

Hay’addu waxay bayaan ay soo saartay ku sheegtay in 31-kii Luulyo, 833 xaaladood oo cudurkan neerfaha ah laga soo sheegay adduunka oo dhan, halka laga soo bilaabo Luulyo 25, in ka badan 592 milyan oo qiyaasood oo tallaalka “Vaxepsyria”, oo ay soo saartay AstraZeneca, la helay. siiyey.

"Guddiga Qiimaynta Khatarta Pharmacovigilance-ka ee Wakaaladda Daawooyinka Yurub ayaa soo gabagabeeyey in xiriirka sababa ee ka dhexeeya tallaalka Vaxepheria iyo Guillain-Barré syndrome uu yahay ugu yaraan suurtagal macquul ah," ayaa lagu yiri bayaanka.

"Sidaas awgeed, Guillain-Barré syndrome waa in lagu daraa macluumaadka alaabta si ay u saameynayso Vaxsyphria," ayay ku dartay wakaaladda fadhigeedu yahay Amsterdam.

Waxay sharraxday in halista waxyeelladan ay "aad u yar tahay," in ka yar mid ka mid ah tobankii kun.

Guillain-Barré syndrome waa cudur ku dhaca neerfayaasha durugsan oo sababa in ay si tartiib tartiib ah u daciifaan ama xitaa curyaan u noqdaan, inta badan wuxuu ka bilaabmaa lugaha oo mararka qaarkood wuxuu u baxaa murqaha neefsiga kadibna neerfayaasha madaxa iyo qoorta.

Wakaaladdu waxay ku talisay in la cusboonaysiiyo digniinta lagu daray bishii Luulyo macluumaadka badeecada si loo kordhiyo wacyiga khatarta ah ee ka dhex jira xirfadlayaasha daryeelka caafimaadka iyo dadka qaata tallaalka.

Digniintu waxay sidoo kale xasuusineysaa bukaanada inay si degdeg ah u raadsadaan daryeel caafimaad haddii ay yeeshaan daciifnimo ama curyaannimo xagga cirifka ah oo laga yaabo inay gaaraan laabta iyo wejiga.

Bishii Luulyo, wakaaladu waxay liis garaysay isla cilladda "aad u naadir ah" saamaynta soo raaca ee tallaalka "Johnson & Johnson" ee ka dhanka ah Covid-19, kaas oo, sida AstraZeneca, uu isticmaalo tignoolajiyada adenovirus la mid ah.

Gudaha Mareykanka, Hay'adda Dawooyinka Mareykanka waxay bishii Luulyo ka digtay "khatarta kordhaysa" ee lagu horumarinayo cudurkan "Guillain-Barré syndrome" ee dadka helay tallaalka "Johnson & Johnson" ee ka dhanka ah Covid-19.

Laakin labada wakaaladoodba waxay carabka ku adkeeyeen in faa'iidooyinka labada tallaal ay aad uga miisaan badan yihiin khatartooda.

Fayraska Corona ayaa sababay dhimashada ugu yaraan 4,583,765 qof oo adduunka ah tan iyo markii xafiiska Hay'adda Caafimaadka Adduunka ee WHO uu sheegay in cudurka uu soo shaac baxay dhammaadkii Disembar 2019.

Dalka Maraykanka ayaa ah dalka ugu badan ee ay dadka u dhinteen, waxaana ku xiga Brazil, India, Mexico iyo Peru, marka loo eego tirooyinka rasmiga ah.

Ururka Caafimaadka Adduunka, iyada oo tixgalinaysa heerka dhimashada xad-dhaafka ah ee dhimashada tooska ah ama si dadban ee la xidhiidha Covid-19, waxa ay tixgelisaa in natiijada faafitaanka ay laba ama saddex jeer ka badan tahay natiijada sida rasmiga ah loo shaaciyey.

Mawduucyo kale: 

Sidee ula macaamishaa jaceylkaaga ka dib markaad ka soo laabato kala tag?

http://عادات وتقاليد شعوب العالم في الزواج

Ryan Sheekh Maxamed

Ku-Xigeenka Tafatiraha Guud iyo Madaxa Waaxda Xiriirka, Bachelor of Engineering Civil - Department Topography - Jaamacadda Tishreen oo lagu tababaray is-hormarinta

Maqaallada la xiriira

Tag badhanka sare
Hadda ku biir Ana Salwa si bilaash ah Marka hore waxaad heli doontaa wararkayaga, waxaanan kuu soo diri doonaa ogeysiin ku saabsan mid kasta oo cusub Llaa Haa
Baahinta Tooska ah ee Warbaahinta Bulshada Waxaa ku shaqeeya: XYZScripts.com